Concord Biotech IPO Details | GMP, Date, Price, Review

Concord Biotech IPO Details ( Concord Biotech Limited IPO Review )

(04 Aug 2023 – 08 Aug 2023)

Concord Biotech Limited, founded in 1984, is an Indian biopharmaceutical company with a strong focus on research and development. Specializing in fermentation-based Active Pharmaceutical Ingredients (APIs) within the immunosuppressants and oncology segments, the company has earned a prominent position among global developers and manufacturers based on market share by volume in 2022.

With a widespread presence worldwide, Concord Biotech supplies its products to more than 70 countries, including major markets like the USA, India, Europe, and Japan.

The company’s expertise lies in manufacturing APIs through fermentation and semi-synthetic processes, as well as producing finished formulations. Starting with a single product, Concord Biotech has expanded its offerings to become a comprehensive solution provider.

Their product portfolio covers therapeutic segments such as Immunosuppressants, Anti-bacterial, Oncology, Antifungals, and more, drawing interest from customers across the globe. Additionally, Concord boasts a promising pipeline of products currently under development.

Concord Biotech IPO Listed On ₹900.05 & Listing Gain 21.46%

Concord Biotech IPO Listing Day Trading Information:

Concord Biotech IPO	Data
BSE Symbol	543960
NSE Symbol	CONCORDBIO
Listing Date	18 August 2023
Issue Price	₹705 to ₹741
Listed Price	₹900.05
Open	₹900.05
Low	₹900.05
Listing Gain	21.46%

Concord Biotech Limited Company Product

• Formulations
• APIs

Concord Biotech Limited IPO Competitive Strength

• Established presence across the complex fermentation value chain
• Global leadership in immunosuppressant APIs along with a wide spectrum of complex fermentation-based APIs across multiple therapeutic areas
• Scaled manufacturing facilities with a consistent regulatory compliance track record and supported by strong R&D capabilities
• Diversified global customer base with long-standing relationships with key customers
• Experienced Promoters, management team supported by marquee investors
• Financial track record of rapid growth and consistent profitability with healthy cash flows and strong shareholder returns

Concord Biotech IPO Financials Performance ( Results )

Concord Biotech Limited Financial Information (Restated Consolidated)

All Amount in ₹ Crores

Period Ended	Total Assets	Total Revenue	PAT	EPS (₹)	Net Worth	Reserves	Borrowing
31-Mar-21	1,182.55	630.75	234.89	22.45	999.37		86.35
31-Mar-22	1,312.80	736.35	174.93	16.72	1,103.22		60.59
31-Mar-23	1,513.98	888.48	240.08	22.95	1,290.00		31.24

Objective of IPO Issue

• Achieve the benefits of listing the Equity Shares on the Stock Exchanges and
• Carry out the Offer for Sale of up to 20,925,652 Equity Shares by the Selling Shareholder.

Concord Biotech IPO Basic Details

IPO Date	Aug 4, 2023 to Aug 8, 2023
Listing Date	Friday, August 18, 2023
Face Value	₹1 per share
Price	₹705 to ₹741 per share
Lot Size	20 Shares
Issue Size	20,925,652 shares (aggregating up to ₹1,551.00 Cr)
Offer for Sale	20,925,652 shares (aggregating up to ₹1,551.00 Cr)
Issue Type	Book Built Issue IPO
Employee Discount	Rs 70 per share
Listing At	NSE, BSE
Share holding pre issue	104,616,204
Share holding post issue	104,616,204
Company Promoters	Sudhir Vaid And Ankur Vaid

Concord Biotech IPO Anchor Investors Basic Details

Bid Date	Aug 3, 2023
Shares Offered	6,274,695
Anchor Portion Size (In Cr.)	₹464.95
Anchor lock-in period ends in 30 days for 50% shares.	Sep 26, 2023
Remaining shares anchor lock-in period ends in 90 days.	Dec 26, 2023
Concord Biotech IPO Anchor Investors list Details	Download

Concord IPO Reservation

QIB Shares Offered	50% of the Net Issue
NII (HNI) Shares Offered	15% of the Net Issue
Retail Shares Offered	35% of the Net Issue

Concord IPO Timetable

Concord IPO will open on August 4, 2023 and close on August 8, 2023. You can join Concord Biotech IPO at 10.00 A.M. to 5.00 p.m. Upto which mandate can be applied.

Event	Date
Opening Date	4 August 2023 (Friday)
Closing Date	8 August 2023 (Tuesday)
Basis of Allotment	11 August 2023 (Friday)
Initiation of Refunds	14 August 2023 (Monday)
Credit of Shares to Demat	17 August 2023 (Thursday)
Listing Date	18 August 2023 (Friday)
Deadline for UPI mandate confirmation	5 PM on 8 August 2023

Concord Biotech IPO Lot Size

For retail investors in Concord Biotech IPO, 20 shares will come in 1 lot or the minimum investment will be ₹000,000. Retail-individual investors can apply for up to 1 lots or the maximum investment will be ₹000,000.

Application	Lots	Shares	Amount
Retail (Min)	1	20	₹14,820
Retail (Max)	13	260	₹192,660
S-HNI (Min)	14	280	₹207,480
S-HNI (Max)	67	1,340	₹992,940
B-HNI (Min)	68	1,360	₹1,007,760

Concord Biotech IPO Promoter Holding

The company’s promoters include Sudhir Vaid And Ankur Vaid.

Pre Issue Share Holding	44.08%
Post Issue Share Holding	44.08%

Concord Biotech Ltd IPO Key Performance Indicator ( Valuation )

In the table given below, all the figures have been told according to the latest financial year.

KPI	Values
Market Cap (₹ Cr.)	7752.06
Earning Per Share (EPS)	₹22.95 per Equity Share
Net Asset Value (NAV)	₹123.31 per Equity Share
P/E Ratio (P/E) (x)	32.29
Return on Net Worth (RoNW) (%)	20
Return on equity (ROE) (%)	20.06
Return on Capital Employed (ROCE) (%)	24.27
Debt/Equity Ratio	0.02

Concord Biotech Ltd Peer Comparison

P/E Ratio has been computed based on the closing market price of equity shares on NSE on July 25, 2023, divided by the Diluted EPS.

Company Name	Consolidated/ Standalone	Face Value	EPS (₹)	P/E Ratio	RoNW (%)	NAV (₹)
Concord Biotech Limited	Consolidated	1	22.95	32.29	20.06	123.31
Peer Group
Divi’s Laboratories Limited	Consolidated	2	68.69	54.15	14.28	480.93
Suven Pharmaceuticals Limited	Consolidated	1	16.16	30.08	23.70	68.16
Laurus Labs Limited	Consolidated	2	14.64	23.70	19.68	75.16
Shilpa Medicare Limited	Consolidated	1	-3.74	NA	NA	204.41

Concord Biotech IPO GMP Live Update, Kostak Rate day by day

Date	GMP	Kostak	Subject to
16 August 2023	₹122	–	–
15 August 2023	₹122	–	–
14 August 2023	₹122	–	–
13 August 2023	₹122	–	–
12 August 2023	₹122	–	–
11 August 2023	₹122	–	–
10 August 2023	₹122	–	–
9 August 2023	₹122	–	–
8 August 2023	₹122	–	–
7 August 2023	₹155	–	–
6 August 2023	₹155	–	–
5 August 2023	₹199	–	–
4 August 2023	₹188	–	–
3 August 2023	₹185	–	–
2 August 2023	₹185	–	–
1 August 2023	₹180	–	–

Concord Biotech IPO Detail Video:

link

Concord Biotech IPO Subscription Status (Bidding Detail)

The Concord Biotech IPO on August 8, 2023 at 7:30:00 PM was subscribed 24.87 times, with the retail category being subscribed 3.78 times, the NII (Non-Institutional Investor) category being subscribed 16.99 times, the QIB (Qualified-Institutional Buyers) category being subscribed 67.67 times and the Employee category being subscribed 24.48 times.

Category	Subscription
QIB	67.67x
NII	16.99x
Retail	3.78x
Employee	24.48x
Total	24.87x

Concord Biotech IPO Prospectus

Concord Biotech IPO DRHP	Download
Concord Biotech IPO RHP	Download
Concord Biotech IPO Anchor Investors Details PDF	Download

Concord Biotech IPO Rating

Our Rating

2.5/5.0

Concord Biotech Company Contact Information

Concord Biotech Limited

Registered Office: 1482-86, Trasad Road, Dholka, Ahmedabad
– 382225, Gujarat, India
Corporate Office: 16th floor, B-Wing, Mondeal Heights, Iscon Cross Road,
S.G. Highway, Ahmedabad – 380015, Gujarat, India;
Contact Person: Prakash Sajnani, Company Secretary and Compliance Officer, and Assistant Vice President (Finance)
E-mail: complianceofficer@concordbiotech.com
Website: www.concordbiotech.com
Telephone: 079-6813 8700
Corporate Identity Number: U24230GJ1984PLC007440

Concord Biotech IPO Registrar

Link Intime India Private Limited

Address: C 101, 247 Park L.B.S Marg Vikhroli (West),
Mumbai 400 083 Maharashtra, India
Tel: +91 810 811 4949
E-mail: concordbiotech.ipo@linkintime.co.in
Website: www.linkintime.co.in
Investor Grievance ID: concordbiotech.ipo@linkintime.co.in
Contact Person: Shanti Gopalkrishnan
SEBI Registration Number: INR000004058

Concord Biotech IPO Lead Manager

Kotak Mahindra Capital Company Limited

Address: 1st Floor, 27 BKC, Plot No. 27 G Block, Bandra Kurla Complex
Bandra (East), Mumbai 400 051, Maharashtra, India
Tel: +91 22 4336 0000
E-mail: cbl.ipo@kotak.com
Website: https://investmentbank.kotak.com
Investor Grievance ID: kmccredressal@kotak.com
Contact Person: Ganesh Rane
SEBI Registration Number: INM000008704

Citigroup Global Markets India Private Limited

Address: 1202, 12th Floor, First International Financial Centre,
G Block Bandra Kurla Complex, Bandra (East), Mumbai 400 098
Maharashtra, India
Tel: +91 22 6175 9999
E-mail: concord.ipo@citi.com
Website: http://www.online.citibank.co.in/rhtm/citigroupglobalscreen1.htm
Investor Grievance ID: investors.cgmib@citi.com
Contact Person: Karan Singh Hundal
SEBI Registration Number: INM000010718

Jefferies India Private Limited

Address: Level 16, Express Towers Nariman Point,
Mumbai 400021 Maharashtra, India
Tel: +91 22 4356 6000
E-mail: Concord.IPO@jefferies.com
Website: www.jefferies.com
Investor Grievance ID: jipl.grievance@jefferies.com
Contact Person: Suhani Bhareja
SEBI Registration Number: INM000011443

Concord Biotech IPO FAQs